Biogen Inc
Change company Symbol lookup
Select an option...
BIIB Biogen Inc
NTCT Netscout Systems Inc
CIO City Office REIT Inc
HMHC Houghton Mifflin Harcourt Co
PBA Pembina Pipeline Corp
ZTS Zoetis Inc
HMPT Home Point Capital Inc
KWR Quaker Chemical Corp
TWO Two Harbors Investment Corp
BV Brightview Holdings Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.

Closing Price
$272.11
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
996,264
0
  • Prev Close
    272.11
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    996.3K
  • Last (time)
    3:59p ET 05/06/21
  • Last (size)
    5
  • 52-Wk Range
    223.25 - 363.92
    LowHigh
  • (11/04/20 - 11/09/20)
    21.89%
  • 58.2%
  • Market Cap
    41.0B
  • Shares Outstanding
    150.6M
  • --
  • --x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • --

Latest News

May 06, 2021
5:00 pm ET
Zacks
April 28, 2021
6:20 pm ET
Globe Newswire
7:30 am ET
Globe Newswire
April 22, 2021
12:36 pm ET
MarketWatch
7:47 am ET
MarketWatch
7:17 am ET
MarketWatch
7:17 am ET
MarketWatch
7:16 am ET
MarketWatch
7:16 am ET
MarketWatch
April 20, 2021
8:30 am ET
PR Newswire
April 19, 2021
7:30 am ET
Globe Newswire
April 16, 2021
7:30 am ET
Globe Newswire
April 15, 2021
4:30 pm ET
Globe Newswire
April 14, 2021
4:06 pm ET
Globe Newswire
April 12, 2021
7:00 am ET
BusinessWire
April 09, 2021
4:30 pm ET
Globe Newswire
April 08, 2021
7:00 am ET
Globe Newswire
April 07, 2021
7:30 am ET
Globe Newswire
March 24, 2021
11:21 am ET
Globe Newswire
March 04, 2021
8:06 am ET
MarketWatch
7:47 am ET
Globe Newswire
March 02, 2021
9:15 am ET
PR Newswire
February 24, 2021
7:37 am ET
Globe Newswire
February 11, 2021
8:03 am ET
Globe Newswire
8:00 am ET
Globe Newswire
7:30 am ET
Globe Newswire
February 10, 2021
1:02 pm ET
Globe Newswire
1:00 pm ET
Globe Newswire
February 03, 2021
8:21 am ET
MarketWatch
January 29, 2021
11:40 am ET
MarketWatch
January 11, 2021
11:42 am ET
MarketWatch
November 28, 2020
5:34 pm ET
MarketWatch
November 27, 2020
8:18 am ET
MarketWatch
8:03 am ET
MarketWatch
7:32 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.